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INTRODUCTION 
 
 Type – 2 Diabetes Mellitus is an epidemic in India for the past few 
decades. Diabetes mellitus is a very important risk factor associated with 
two to four fold increased incidence of Coronary heart disease. 
 
 Even though disease of small blood vessels is specific to diabetes 
mellitus large vessels disease is very common in treated diabetes and 
accounts for about 70% of all the deaths. 
 
 Hyperuricemia is one the component of Syndrome – X in Type-2 
diabetes mellitus. But exact pathogenesis role of uric acid in coronary heart 
disease is not known. Uric acid was recognized as atherosclerosis marker in 
type-2 DM and it was correlated with the presence of CHD independently of 
hypertension and nephropathy. 
 
 Combination of risk factors in coronary disease play role in morbidity 
and mortality in patients with coronary heart disease of type-2 diabetes 
mellitus among which diabetic dyslipidemia plays major role. 
 
 
  
 
 
 
 
AIM OF THE STUDY 
 
1. To establish the association of elevated serum uric acid concentration 
as a marker of coronary artery disease in type -2 diabetic patients. 
2. To establish the association of uric acid level in relation to other risk 
factors of coronary artery disease in type – 2 diabetic patients. 
 
 
 
 
 
 
 
 
 REVIEW OF LITERATURE 
 
 During recent year’s cardiovascular disease have registered a sharp 
increase in Indian subcontinent. The risk of coronary heart disease in Indians 
is three to four times higher than white Americans, six times more than 
Chinese and twenty times more than in Japanese. 
 A sharp increase in the incidence of type – 2 diabetes mellitus in 
Indian is explained by the “westernized” life style such as overeating in 
combination with obesity and under activity. Strong genetic predisposition is 
confirmed, probably of polygenic inheritance. Increasing age is an 
independent risk factor for NIDDM. 
 NIDDM predisposes to Coronary heart disease by its unique 
metabolic disturbance affecting homeostasis of the individual. Obesity, 
systemic hypertension, Hypercholesterolemia is associated with NIDDM, as 
a result of insulin resistance state. But in Indians who have smaller body 
frames than western people still had high incidence of NIDDM and CHD. 
 The four major risk factors for CAD viz hypercholesterolemia, 
hypertension, diabetes mellitus and cigarette smoking which were present in 
Framingham’s cohort are difficult to explain among Indians with CAD. 
CAD in Indians is present with low cholesterol level. In contrast insulin 
resistance is much more prevalent in Indians. Hyperinsulinemia, impaired 
fasting glucose, hypertriglyceridemia, abdominal obesity, hypertension and 
Low HDL  commonly referred to as syndrome – X is important in Indian 
context.  
 Apart from dyslipidemia nonlipid risk factors for coronary heart 
disease in NIDDM are Hypertension, aging, male sex, smoking alcohol, 
body mass index, waist to hip ratio. Evidence is emerging in favor newer 
risk factors like high Plasminogen activator inhibitor – l (PAI – I), raised 
fibrinogen levels,presence of lipoprotein(a), low levels of Apo –A, high 
levels of Apo –B, LDL and IDL and particularly small dense LDL. 
 NIDDM is associated with following risk factors for atherosclerosis. 
They have been divided in to two major types – Non lipid risk factors and 
Lipid risk factors. 
   
      
 
 
 
 
 NON LIPID RISK FACTORS FOR ATHEROSCLEROSIS IN 
TYPE-2 DM 
Body Mass Index 
 Obesity  is a  state of  adipose  tissue having a body mass index more 
than 30kg/m2. Assessment of BMI (weight in kg divided by height in square 
meters) has the advantage of simplicity and is useful for assessing both 
undernutrition and overnutirion. It is a widely used means of energy balance, 
but it does not take into account the differences in frame size. As the Indian 
population is more of smaller frame than other western countries BMI alone 
was not sufficient as a marker of risk factor in type – 2 diabetes mellitus of 
coronary heart disease. 
 
Central Obesity 
 Central obesity is defined as increased ratio of waist to hip 
circumference measured at the level of umbilicus and pubic symphysis 
respectively. It differs in males and females because of difference in body fat 
content. 
 Normal W/H ratio in males is <0.85 and in females <0.90. This is the 
most important factor for insulin resistance in type -2 diabetics. The possible 
mediator of insulin resistance in type -2 DM is central obesity lead to 
elevated free fatty acid levels. This leads to inhibition of insulin stimulated 
glucose utilization in muscles via “Randle effect”( the inhibition of 
oxidation of glucose by an excess of fatty acids)which stimulated hepatic 
glucose output, inhibit hepatic clearance of insulin. 
 
Physical Inactivity 
 Regular physical activity has been shown to reduce the risk for 
coronary artery disease events in number of observational epidemiological 
studies. In 10 year follow up of MRFIT subjects, subjects in both treatment 
groups who engaged in moderate physical activity had a 27% lower 
mortality than less active subjects. The mechanism by which increased 
exercise decreases the risk for coronary artery disease events include 
improvements in high density lipoprotein cholesterol level, insulin resistance, 
body weight and blood pressure. Exercise also increases maximal cardiac 
output and the amount of oxygen extracted from the blood. 
 
 
 
 
Type A Personality and Stress 
 Type A personalities are highly competitive, ambitious, and in 
constant struggle with their external environment, whereas type B 
personalities are passive and less disturbed by the environmental stimuli. 
The mechanism by which personality types may predispose to increased 
coronary risks is not known but may include increased cardiovascular 
reactivity, which may lead to increased endothelial injury and platelet 
aggregation, and increased sympathetic nervous system activity, which 
increase the blood pressure and heart rate. 
 
Low Circulating Levels of Anti-Oxidants 
 Blood concentrations of anti-oxidants may effect the susceptibility of 
low density lipoprotein cholesterol and lipoprotein (a) to oxidation. Because 
lipoprotein oxidation is thought to be prerequisite to the recognition of these 
particles by the scavenger receptors on the macrophages, decreased level of 
substances that protect against oxidation may improve the atherosclerotic 
risk. 
 
 
 
Hyperglycemia  
 The major and simplest parameter for the assessment of diabetic status 
and also an important risk factor for the pathology and pathophysiology of  
the disease process  in diabetes mellitus. The important mechanism 
underlying in the pathogenesis of long term complications of diabetes 
mellitus by hyperglycemia is nonenzymatic glycation of the various 
important proteins and structural and functional enzymes. This leads to 
increased levels of oxidized LDL which is more atherogenic and when the 
HDL undergoes nonenzymatic glycation that leads to decreased reverse 
transport of cholesterol from the vessels wall to the liver ultimately leading 
to diabetic dyslipidemia and increased incidence of atherogenecity. 
Nonenzymatic glycation of structural proteins in the vessel wall leads to 
thickening of basement membrane and hyalinization.  
 Other important mechanism involved in increased atherogenicity is by  
¾ Enhanced TX-A2 synthesis  
¾ Decreased PGI2 synthesis  
¾ Increased secretion of endothelin in vitro 
¾ Increase in arterial endothelial permeability 
 
 
Tissue Type Plasminogen Activator (t-PA) 
 t-PA is synthesized in endothelial cells, and is an important 
anticoagulant. In the presence of endothelial dysfunction, fibrinolysis is 
retarded in arteries rendering them ripe for fibrin deposition and 
development of thrombus. Following thrombolysis, there is extensive 
damage to the endothelial lining. This may also explain the occurrence of 
reocclusion following successful thrombolytic therapy. Plasma levels of    t-
PA appear to be inversely related to high density lipoprotein cholesterol 
levels. 
 Although counter-intuitive, plasma levels of endogenous t-PA are 
increased in subjects with atherosclerosis and acute coronary syndrome. 
Elevated levels of t-PA also found to be an independent predictor of CAD in 
large European studies. Asian Indians also have high levels of t-PA than 
Chinese in Singapore. This may be reflection of a state of endothelial 
activation. 
 
Plasminogen Activator Inhibitor – 1 
 Plasminogen activator inhibitor – 1 is single chain glycoprotein that 
forms stable complexes with t-PA and urokinase type plasminogen activator, 
and inhibit fibrinolytic activity. Its levels are highly correlated with serum 
triglyceride levels. Because of its procoagulant effect, high levels of PAI-1 
serve as a marker for increased thrombogenesis. Recent studies indicate an 
inverse relation between PAI-1 and dietary fiber, and the cardio protective 
effect of high fibre diet may be mediated through lowering the PAI-1 levels. 
Asian Indians have a higher level of PAI-1 than Chinese in Singapore and 
whites in UK and the US. High levels of PAI-1 levels are predictive of 
premature CAD in whites and may contribute to higher rates of CAD among 
Asian Indians. 
 
 
Homocysteine  
 At the cellular level homocysteine down regulates endothelial 
thrombomodulin function, affects the activation of protein-C and impairs 
plasmin generation by inhibiting binding of t-PA to the endothelial receptors. 
Homocysteine augments the deposition of Lp(a) on fibrin surfaces and its 
pathological effects are exponentially increased with the concomitant 
presence of elevated Lp(a) and factor V Leiden. Elevated levels of 
homocysteine are a powerful risk factor for thrombogenesis, atherogenesis, 
and premature CAD. About 12% to 40% of patients with premature vascular 
disease have mild moderate hyperhomocysteinemia. The normal plasma 
homocysteine level range from 4.4 – 10.8 micromoles/L. and increased risk 
of CAD starts at a concentration of 10 micromoles/L. 
 
Lipoprotein (a) 
 High levels of lipoprotein (a) are evolving to be another genetically 
linked risk factor in thrombogenesis. Apo-A competitively binds to 
plasminogen receptor and inhibits the conversion of plasminogen to plasmin. 
The inhibition of naturally occurring t-PA creates a prothrombotic state, 
resulting in local thrombus formation. It may represent an important link 
between atherogenesis and thrombogenesis. Lp(a) level more than 20 – 
30mg/dl are associated with 2-3 fold increase in the risk of CAD, which 
increases exponentially with the concomitant presence of low HDL-C and 
high total/HDL-C ratio, or high homocysteine, all of which are common 
among Asian Indian. 
 
Fibrinogen, Factor VII and Blood Viscosity 
 Serum fibrinogen level, coagulation factor VII activity, and blood 
viscosity are some of the well-studied haemostatic risk factors for CAD. 
Fibrinogen is a cofactor of platelet aggregation. Fibrinogen levels are higher 
in patients that develop ACS or CAD deaths. This association is independent 
of other coronary risk factors and has the same predictive value as elevated 
serum cholesterol levels. 
 
Platelet Activity  
 Platelets play a crucial role in endothelial dysfunction, coagulation, 
and thrombosis. The participation of platelets in thrombotic process depends 
on their ability to adhere to an abnormal surface and aggregate to form an 
initial platelet plug. The activation of platelets stimulates further platelet 
aggregation and triggers the coagulation cascade. Platelet activity is highest 
in the early morning hours and enhanced by high fat diet and is reduced by 
aspirin therapy. 
 
Endothelial Dysfunction 
 Vascular endothelium is an active site of protein synthesis and may be 
considered as one of the most important paracrine organ in human body. The 
endothelial cells synthesize, secrete, modify and regulate connective tissue 
components, vasodilators, constrictors, anticoagulants, fibrinolytic 
compounds, and prostanoids, each contributing to the maintenance of the 
vascular tone, thromboresistance, and physiological homeostasis. There are 
number of reports indicating endothelial dysfunction in patients with CAD 
“risk profile”. Whether Asian Indians suffer from endothelial dysfunction 
and if it relates to the coronary risk profile has not been studied. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 LIPID RISK FACTORS FOR ATHEROGENESIS IN  TYPE-
2 DM 
 Dyslipidemia is one of the major contributors to atherosclerosis in 
diabetes but clustering of risk factors is also more frequent in diabetic 
patients. Dyslipidemia in type -2 diabetes is as follows. 
 
Triglycerides 
 Although many mechanisms contribute to the development of 
hypertriglyceridemia in type-2 diabetes insulin resistance seems to be a 
common basis. The insulin resistance state impairs the normal suppression 
of fatty acid release from the adipose tissue in the postprandial state. Thus 
flux of free fatty acids of the liver increases and overproduction of VLDL 
from these substrates occurs when hyperinsulinemia is present. 
 The catabolism of TGL rich lipoproteins is initiated by lipoprotein 
lipase which hydrolyzes the triglyceride moiety of chylomicrons and the 
VLDL and releases free fatty acids for energy production in muscle and 
storage in adipose tissue. The activity of lipoprotein lipase enzyme is lower 
in type-2 diabetes. In type-2 diabetes, the passage of TGL rich lipoprotein 
through the lipolytic cascade is delayed for two reasons  1) there is shortage 
of catalytic sites on LPL   2) overproduction of TGL saturates the sites that 
are available. Both mechanisms promote hypertriglyceridemia. 
 
 
 
Very Low Density Lipoprotein – C 
 Insulin is also is involved in another defect of VLDL metabolism. 
Acute hyperinsulinemia such that after a meal suppresses the production of 
large buoyant VLDL particles in the liver (VLDL-1) in the nondiabetic 
people but not in type-2 diabetes patients. VLDL-1 particles are analogous 
to chylomicrons which should be released only in fasting state when lipids 
from food are not available, thus insulin functions in nondiabetic people to 
maintain the balance between intestinally derived and liver derived TGL rich 
proteins. In type-2 diabetes patients this regulation fails, inappropriate 
production of VLDL by the liver occurs and the balance favors 
hypertriglyceridemia. 
 
Low Density Lipoprotein –C 
 There is an increased transfer of cholesteryl esters from LDL to TGL 
from VLDL to LDL. The TGL enriched LDL loose their TGL by the  
 action of hepatic lipase resulting in the formation of small dense LDL. Again 
nonenzymatically glycated LDL by chronic hyperglycemia of diabetes leads 
to decreased clearance from the circulation and thereby increased incidence 
of atherogenecity. 
 
 
High Density Lipoprotein – C 
 The high levels of TGL rich lipoproteins and low levels of HDL are 
interwoven. Hypertriglyceridemia contributes to low levels of HDL in two 
ways. Because the lipolysis is impaired in type-2 diabetes, there few surface 
remnants available to be incorporated into the HDL particles. Second the 
large amount of TGL rich lipoproteins and their prolonged resistance time in 
circulation increase the exchange (mediated by CETP) of esterified 
cholesterol from HDL to TGL rich lipoproteins and of TGL and HDL 
particles. The resultant is enrichment of the HDL particle core with TGL. 
The enriched HDL has a faster catabolic rate than normal HDL, which leads 
to lower number of circulating HDL particle 
 
 
ROLE OF URIC ACID IN NIDDM 
Uric Acid Metabolism   
         It was carl wihelm Scheele in 1776 isolated uric acid from urine. 
Marcet in 1819 discovered xanthine. Strecker in 1857  showed the presence 
of uric acid in urine. In 1892, Sir frederirk Hopkins (nobel prize,1929) 
estimated uric acid. In 1895 , Emil fischer showed that uric acid is derived 
from purine nucleus. 
 
 Uric acid is the final breakdown product of purine metabolism. It is a 
weak acid with pKas of 5.75 & 10.3. Urates the ionized form of uric acid, 
predominate in plasma, ECF, and synovial fluid, with approximately 98% 
existing as monosodium urate at pH of 7.4. MSU easily ultra filtered and 
dialyzed from the plasma. 
 
 Although purine nucleotides are synthesized and degraded in all 
tissues, urate is produced in tissues only contain the enzyme xanthine 
oxidase primarily liver and small intestine. The amount of urate produced in 
the body is net result of the amounf produced and the amount excreted. 
  
            
               Serum urate levels vary with age sex. Mean serum uric acid conc. 
In adult and premenopausal women are 6.8mg and 6.0mg/dl respectively. 
After menopause, values for women increase to approximate to those of men 
hyperuricemia is defined as serum urate conc. more than 7.0mg/dl in men 
and 6.0mg/dl in premenopausal women.  
          Hyperuricemia reflects defect in insulin action on renal tubules which 
helps in reabsorption of uric acid.  
 
 
 
                               
                          
 
 
 
 
 
        
                      
URIC ACID METABOLISM 
 
     AMP  PHOSPHOMONOESTERASE    GMP 
Pi           Pi 
  Adenosine     Pi    Guanosine 
AMP     PNPase          GMP 
    Inosine    D-Ribose-I-P  Guanine 
 
Hypoxanthine   XANTHINE OXIDASE   Xanthine 
            XO* 
 
Uric acid 
XO  - Xanthine Oxidase 
PNPase - Purine nucleotide phosphorylase 
Pi  - Inorganic phosphate 
AMP  - Adenosine monophosphate 
GMP  - Guanosine monophosphate 
 
 
 
FACTORS THAT AFFECT URATE LEVEL IN 
TYPE -2 DIABETES MELLITUS 
Dietary Habits 
 An increase in serum urate level may occur in type-2 DM in various 
situations like purine rich diet such as Non-vegetarian diets – liver, 
anchovies, kidneys, sardines and sweet breads and yeasts. 
 
Exercise 
 Exercise acutely increases serum urate levels by excessive 
degradation of skeletal ATP. 
 
Alcohol 
 Alcohol increases serum urate level by accumulation of organic acids 
(beta hydroxyl butyrate, aceto-acetate, lactate) that compete with the urate 
for tubular secretion and accelerated breakdown of ATP by liver is increased. 
(Beer contains high uric acid) 
 
 
 
 
 Obesity 
 Various mechanisms play role in increase of serum urate by obesity 
like anabolic effects of tissues because of insulin resistance, increase in de 
novo biosynthesis of purines decreased excretion and increased breakdown. 
 
Dehydration 
 Dehydration can impair uric acid excretion by decreased filtration and 
secretion and sometimes with the acidosis by competition of H+ ions for 
excretion. Starvation again causes accumulation of organic acids that 
compete for the excretion of urate for tubular secretion. 
 
Systemic Hypertension 
 There are various studies regarding association of systemic 
hypertension with the elevated uric acid levels. Probable mechanism 
suggested is impaired excretion of urate because of intrinsic renal defect in 
HT. 
 
 
 
 Lactic Acidosis and Diabetic Ketoacidosis 
 Dehydration and prerenal azotemia both can impair filtration and 
secretion of urate leading to retention and also there may be diminished 
reabsoption of the uric acid. Again in the setting of acidosis H+ ions 
compete with uric acid leading to enhanced reabsorption and retention. 
 
Hyperglycemia 
 Both uric acid and glucose levels are positively related o body mass 
index. The association of uric acid in relation to glucose reflects the 
biochemical interaction between serum glucose and purine metabolism. 
(Deranged carbohydrate metabolism) 
 
Renal Insufficiency 
 Decreased urate filtration contributes to the hyperuricemia of renal 
insufficiency. But the correlation between BUN, serum creatinine and serum 
uric acid concentration is poor because although uric acid excretion per unit 
of GFR increases progressively with renal insufficiency, the tubular 
secretory capacity tends to be preserved, the tubular reabsorptive capacity is 
decreased and extrarenal clearance of uric acid increases as the renal damage 
becomes more severe. 
 
Drugs 
 They mainly act by decreasing the uric acid excretion by competitive 
inhibition of uric acid excretion. 
 Salicylates and nicotinic acid directly compete with the urate for 
tubular secretion. 
 Diuretics decrease the secretory capacity and increase reabsorption. L-
Dopa, pyrazinamide, ethambutol, cyclosporine also decrease the secretion of 
urate by the tubules. 
 
 
INTERACTION OF URIC ACID AND LIPOPROTEIN 
METABOLISM 
 One of the recent concepts in atherogenic risk factor is association of 
elevated triglycerides in which insulin resistance seems to be a common 
basis. Insulin resistance state impairs the normal suppression of fatty acid 
release from the adipose tissue in the postprandial state. Thus flux of free 
fatty acids to the liver increases and overproduction of VLDL from these 
substances occurs. 
 There various studies arguing in favor as well as against the serum 
uric acid level as a significant risk factor for the coronary artery disease. 
 
 
 
HYPERURICEMIA IN CORONARY ARTERY DISEASE 
 
 There are studies regarding hyperuricemia as one of the risk factor as 
early as 1977. Jacobs D et al. compared among patients with Myocardial 
Infarction, ischemia, non-ischemic whites and South African blacks. The 
difference in serum uric acid levels between the ischemic and infarction 
groups was highly significant. 
 
 Tkac l et al studied 91 type-2 DM, 57 patients with Myocardial 
infarction were compared with control group of 34 diabetics without clinical 
or electrolcardiographic signs of ischemic heart disease. Higher mean serum 
uric acid level in infarction group was associated with increasing age and 
serum creatinine levels. It was associated with elevated TGL, BMI and H/o 
hypertension.  
 
 Study of large group of by Persky VW et al concluded, that the 
association between uric acid and the prevalence of ECG abnormalities and 
with the mortality appear to be secondary to association between serum uric 
acid and other risk factors. 
 
 Woo J et al study results found positive association between serum 
uric acid concentration and BMI, WHR, systolic and diastolic BP, urea, 
creatinine, fasting glucose, 2 hour insulin, TGL, apolipoprotein – B in men. 
Similar but fewer associations were seen in women with additional positive 
association with age. The study suggests that serum uric acid may be a 
marker for the presence of an adverse cardiovascular risk profile.  
 
 Wannamethee SG et al concluded in their study that serum uric acid is 
not a truly independent risk factor for coronary artery disease. Increased 
serum uric acid appears to be an integral part of the cluster of risk factors 
associated with the insuline resistance syndrome that include central obesity, 
increased serum trigluceride and serum cholesterol. 
  Pearl A et al study concluded high molar equivalent serum antoxidant 
capacity (MESA) between diabetics and nondiabetics showed, uric acid as a 
free radical scavenger in NIDDM. 
 
 Brand FN et al according to original Framingham heart study 
concluded that serum uric acid predicted subsequent development of CAD, 
in general and myocardial infarction in particular, but not angina. In 
multivariate analysis, including age, systolic BP, serum cholesterol, serum 
uric acid did not add independently to the prediction of CAD. 
 
 Reunanen A et al concluded that any apparent association between the 
adverse cardiovascular outcomes is probably due to the association of uric 
acid level with the other risk factors. 
 
 Corella D et al study concluded that the prevalence of hyperuricemia 
varies with the simultaneous presence of other classical cardiovascular risk 
factors. 
 Chu NF et al studied the relationship between hyperuricemia and 
other cardiovascular risk factors among the adult males in Taiwan. From the 
study they concluded that hyperuricemia is associated with overweight, 
hypertension, and hyperlipidemia. There is a significantly positive 
association between serum uric acid concentration and other cardiovascular 
risk factors. 
 
 Agamah ES et al, identified the significant association of 
hyperuricemia with high plasma glucose and insulin, total cholesterol level, 
serum TGL, VLDL, LDL, and HDL was significantly lower. 
 
 Rathman W et al assessed the various components of insulin 
resistance syndrome in biracial cohort of young adults. They concluded BMI 
showed strongest positive correlation with the uric acid among insulin 
resistance components. Others are increased fasting insulin, increased TGL 
and decreased HDL. 
  
 
 
 
 
 
       STUDIES CONCLUDING URICACID AS A RISK FACTOR 
 
 Lin’ova et al in their clinical and biochemical changes in CAD: 
hyperuricemia as a risk factor, showed positive correlation dependence 
between cholesterol and uric acid, fats and uric acid. The results provided 
the grounds to admit hyperuricemia to be of the risk factors for CAD. 
 
 Rathmann W et al in their study of association of elevated serum uric 
acid with CAD and NIDDM found elevated uric acid associated with body 
weight, hypertention and nephropathy. After adjustment for these 
hypertension and nephropathy a significant correlation existed between 
hyperuricemia and CAD was also found in type-2 diabetes in male diabetics 
independently of hypertension and nephropathy.    
 Alderman M in his study of uric acid in hypertension and 
cardiovascular disease found strong, specific, stepwise independent 
association of increasing uric acid and cardiac morbidity and mortality. 
 
 Huizer T et al in their study of urate production by human heart, 
proved elevated levels of hypoxanthine in coronary sinus venous sample and 
concluded that xanthineoxidoreductase is probably present in the heart of 
patients suffering from CAD, and responsible for the increased urate 
production during transient myocardial ischemia. 
 
 Lehto S et al in their study of “serum uric acid is a strong predictor of 
stroke in patients with NIDDM concluded that hyperuricemia is a strong 
predictor of stroke and overall mortality due to any cause. 
 Longo M Benza B et al in their study of hyperuricemia as risk factor 
of stroke and coronary artery disease among African concluded, 
hyperuricemia as a strong predictor of myocardial infarction in men, stroke 
in both sexes and all causes of mortality in women. 
  Fang J et al in NHANES I epidemiologic follow up study (1971-92), 
concluded that hyperuricemia is independently and significantly associated 
with risk of cardiovascular mortality. 
  
 
 
 
 
 
 
MATERIALS AND METHODS 
 
 Our study included about 93 patients, out of which 7 were excluded 
because they had ischemic changes alone in the ECG. Our study included 
the patients in 2 groups, all of them were diabetic. One group was patients 
without any evidence of coronary heart disease clinically or 
electrocardiographically. They were considered as control group. Those 
patients who had clinical and electrocardiographic evidence of old 
myocardial infarction were another group. There were totally 38 patients in 
control group and 48 patients in the study group. 61 patients were males and 
25 patients were females. 
 
Case Selection 
 The study was done with a random selection of patients suffering 
type-2 diabetes mellitus from wards, OPs, review OPs and diabetic clinic. 
All the studied patients were ambulant, clinically stable with no evidence of 
congestive heart failure due to postmyocardial infarction state or free from 
other major chronic diseases. 
 
 
 Clinical Parameters 
 Following clinical parameters such as duration of diabetes, age of 
onset of the diabetes, history of hypertension, prior history of CAD or 
cerebrovascular accident, smoking, alcoholism was assessed. As most of 
these patients were from the rural areas and semi-urban areas, most of them 
relatively undernourished. 
 
 Body mass index was calculated by measuring the weight and height 
of the patients and using the formula BMI = weight in kg/height in m2. 
Normal BMI ranges from 18.5 to 25.0. 25 -30kg/m2 is considered as 
overweight, and >30kg/m2 were considered to be obese. Our study 
population was small framed individuals most of whom had normal body 
mass index in the range of 18.5 to 25.0kg/m2. Only small group of patients 
formed the group of overweight patients. There was only one patient with 
body mass index more than 30kg/m2. 
 
 Lying and standing BP was measured in all patients to rule out 
autonomic imbalance and none of the patients in our study group had any 
clinical evidence of autonomic neuropathy.  
  
Exclusion Criteria 
 Those patients who were already suffering from chronic diseases such 
as tuberculosis, or chronic leg ulcers were not included in our study. As our 
study was analysis of serum uric acid level with the association of coronary 
artery disease and its associated risk factors, the patients taking the drugs 
that significantly alter the serum uric acid level were also excluded. Patients 
who are already suffered from the ischemic event, most of them were on low 
dose aspirin, which do not affect the serum level of uric acid significantly. 
 
 The patients suffering from any form of renal failure either acute or 
chronic were also excluded from the study. Other patients who were 
suffering from volume overload or volume depletion were also excluded 
from the study as these conditions may significantly affect the serum uric 
acid level. 
 
 
 
 
  
 
Biochemical Parameters 
 As a screening procedure for early renal involvement of kidneys by 
diabetic nephropathy, urine spot protein/ creatinine ratio was done in all 
patients.  
 Our primary end point results were the analysis of serum uric acid 
level in association with the coronary artery disease and its associated risk 
factors. Therefore basic biochemical parameters like blood urea and serum 
creatinine were done in all patients to rule out overt renal failure. 
 
 Fasting and postprandial blood sugar estimation was done to assess 
the glycemic status of the individuals. All the patients were also investigated 
for complete lipid profile, which include total cholesterol, triglycerides, 
VLDL, LDL, and HDL. Total cholesterol was estimated by Allantoin et al 
method and triglycerides by enzyme calorimetric test and HDL by 
precipitation method were directly measured and VLDL was calculated by 
TGL/5 and LDL was calculated by Total cholesterol – (VLDL + HDL). 
Triglyceride level has to be estimated only when there is gross elevation of 
triglycerides more than 400mg/dl. None of our patients had such a higher 
value. 
 
 Serum uric acid level also estimated by using Trinder method (ERBA 
diagnostic kit) in the fasting state, as purine rich diet may influence the 
serum uric acid levels significantly.  
 
 
 Single channel ECG was taken in all patients to assess whether the 
patients suffer from any ischemia or not. Those patients who had old 
myocardial infarction pattern or normal ECG were included. The patients 
who suffered only from ischemia were not included in our study. The 
patients who had nonspecific changes or the evidence of other cardiac 
diseases also excluded from the study.            
 
 
 
 
 
 
 OBSERVATIONS AND RESULTS 
 The analysis was separately done for males and females in which each 
subgroup was analyzed for the presence of hyperuricemia and coronary 
artery disease risk factors and compared with the coronary artery disease 
patients with patients who had no evidence of coronary artery disease and 
the associated risk factors. The analysis was done using the standard error of 
the difference between the means. 
Table -1 shows the results as follows, 
TABLE -1 
CLINICAL PROFILES IN MALES WITH AND WITHOUT 
HYPERURICEMIA 
CLINICAL PARAMETERS PATIENTS WITH NORMAL SUA 
PATIENTS WITH 
HYPERURICEMIA 
Age  55.8+10.3 62.7+7.9 
Obesity (%) 9 27 
Smoking (%) 57 42 
Alcohol (%)  20 15 
Hypertension (%) 17 23 
CAD (%) 37 81 
 
  The above table shows increased incidence of hypertension and 
coronary artery disease and obesity in patients who had elevated serum uric 
acid than those with normal serum uric acid levels. Smoking and alcohol 
was not significantly related to the serum uric acid levels. 
 
 While analysis in the females showed the same results as in males, the 
incidence of coronary artery disease in patients with elevated uric acid level 
was remarkably significant. There was no alcoholic in female patients. 
Obesity and hypertension was found more in association with elevation of 
uric acid level. 
TABLE -2 
CLINICAL PROFILE IN FEMALES WITH AND WITHOUT 
HYPERURICEMIA 
 CLINICAL 
PARAMETERS 
PATIENTS WITH 
NORMAL URIC 
ACID 
PATIENTS WITH 
HYPERURICEMIA 
Age  47.7+8.8 50.1+6.3 
Obesity (%) 0 19 
Hypertension (%) 11 25 
CAD/CVA (%) 11 81 
          The mean age of diabetics in this group is 47.7 years in normal uric 
acid group while it is 50.1 years in hyperuricemia group. 
 There was significant difference among males and females in the 
mean age showing that females had highly elevated uric acid at an earlier 
age in diabetes than males. And there was no significant difference in serum 
uric acid levels in males and females because most of the females were in 
postmenopausal period. 
 Comparison between the biochemical values in both the groups 
showed important differences as follows. 
 
TABLE -3 
BIOCHEMICAL PROFILES IN MALES WITH AND WITHOUT 
HYPERURICEMIA 
BIOCHEMICAL 
PROFILES 
PATIENTS WITH 
NORMAL URIC ACID 
PATIENTS WITH 
HYPERURICEMIA 
BS –F 130+59.6 161+42.9 
BS –PP 255.4+63.3 269.4+60.2 
TC 178.2+42.5 207.5+51.5 
TGL 129.2+41.7 179.9+77.9 
LDL 114.6+42.1 133.3+44.3 
HDL 37.7+4.9 38.5+4.8 
  Mean blood sugar was higher in hyperuricemia group than 
normouricemic group (161 vs 130mgs% of fasting value). There was also 
significant elevation of total cholesterol triglycerides and low density 
lipoprotein in the hyperuricemic group when compared to the 
normouricemic group. 
 
TABLE -4 
BIOCHEMICAL PROFILE IN FEMALES WITH AND WITHOUT 
HYPERURICEMIA 
BIOCHEMICAL 
PROFILES 
PATIENTS WITH 
NORMAL URIC ACID 
PATIENTS WITH 
HYPERURICEMIA  
BS –F 170.1+38.1 198.8+92.8 
BS –PP 281.9+76.3 285.3+83.7 
TC 180.4+33.5 203.9+57.0 
TGL 145.7+60.1 185.8+75.4 
LDL 114.2+32.2 130.0+45.6 
HDL 37.1+2.6 40.0+3.8 
 
 Analysis of the results in females also showed the significant 
difference in all the biochemical values except the postprandial blood sugar, 
which was not significant different with that to the normouricemic group. 
All these factors prove that the patients with multiple risk factors have a 
significant elevation in the uric acid level. Probable mechanism of elevation 
of uric acid in relation to the multiple risk factors denotes the complex 
interaction of these risk factors with uric acid metabolism. 
 
 According to a study by Dr Wun et al, serum uric acid was 
significantly associated with body mass index, history of hypertension, 
serum triglyceride and serum creatinine, but was not related to the control of 
diabetic status. Females were more likely to have more elevated serum uric 
acid levels than in males.  
 
 Bouvenet G et al in the analysis of 1000 cases in relation to the 
association of serum uric acid and serum lipids have found that blood 
triglycerides and blood cholesterol in males were found significantly higher 
in patients with hyperuricemia than normouricemic control subjects. Present 
study also confirms this result even though association of serum cholesterol 
is less strong than serum triglycerides, which is highly significant. 
 
 
  
Clinical profile in coronary artery disease groups 
 Comparison of risk factors between the normal ECG group and old 
infarction group revealed a positive association with the age, smoking and 
hypertension both in males and females. 
 
TABLE -5 
CLINICAL PROFILE OF MALES WITH AND WITHOUT CAD 
CLINICAL PARAMETERS WITH CAD WITHOUT CAD 
Age 60.6+8.8 55.7+10.4 
Obesity (%) 21 26 
Smoking (%) 75 58 
Alcohol (%) 27 16 
Hypertension (%) 35 12 
 
 The above table shows the percentage of risk factors between the 
groups of CAD and no CAD. In males the mean age of diabetes was 60.6 vs 
55.7%, smoking was 75 vs 58% and alcoholism was 27 vs 16% in the CAD 
group and no-CAD group. 
TABLE -6 
CLINICAL PROFILE IN FEMALES WITH AND WITHOUT CAD 
CLINICAL 
PARAMETERS 
WITH CORONARY 
ARTERY DISEASE 
WITHOUT CORONARY 
ARTERY DISEASE 
Age 55.6+7.3 49.8+8.6 
Obesity (%) 21 9 
Hypertension (%) 36 27 
Smoking (%) 7 0 
 
 Table -6 shows the mean age of diabetes in females was 55.6 years vs 
49.8 years, obesity was 21 vs 9%, hypertension was 36 vs 27%, and 
smoking 7 vs 0% in CAD and non-CAD group. 
 
Biochemical profile in coronary artery disease group 
 As a whole both males and females had poor glycemic control, in both 
the groups there was significant elevation total cholesterol, triglycerides and 
low density lipoprotein cholesterol.  
 
 
 
 TABLE -7 
BIOCHEMICAL PROFILE OF MALES WITH CAD AND WITHOUT 
CAD 
BIOCHEMICAL 
PROFILES 
PATIENTS WITH 
CORONARY 
ARTERY DISEASE 
PATIENTS WITHOUT 
CORONARY ARTERY 
DISEASE 
BS –F 175.3+62.7 166.9+45.3 
BS –PP 263.8+61.9 258.3+62.9 
TC 201.7+48.3 176.9+45.6 
TGL 155.7+7.9 144.6+81.4 
LDL 131.5+45.2 111.4+39.8 
HDL 39.2+4.9 36.6+4.5 
  
 Mean fasting blood sugar was 175.3 vs 166.9mg%, total cholesterol 
was 201.7 vs 176.9mg%, Triglycerides was 155.7 vs 144.6mg%, and low 
density lipoprotein cholesterol was 131.5 vs 111.4mg%. There was no 
significant association between the high density lipoprotein cholesterol 
levels. 
 
 TABLE -8 
BIOCHEMICAL PROFILE OF FEMALES WITH AND  
WITHOUT CAD 
BIOCHEMICAL 
PROFILES 
PATIENTS WITH 
CORONARY 
ARTERY DISEASE 
PATIENTS WITHOUT 
CORONARY ARTERY 
DISEASE 
BS –F 206.4 165.5 
BS –PP 293.9 271.5 
TC 285.0 203.8 
TGL 190.7 146.7 
LDL 129.9 117.3 
HDL 39.4 38.5 
 
 In females the mean fasting blood sugar was 206.4 vs 165.5mg%, 
total cholesterol was 285 vs 203.8mg%, triglycerides was 190.7 vs 
146.7mg% and low density lipoprotein cholesterol 129.9 vs 110.3mg%. 
 
 According to cadeddu et al in their study of hyperuricemia and cardiac 
risk factors, there was strict correlation of hyperuricemia and 
hypertriglycerdemia. 
  Recent studies suggest that one of the important, independent risk 
factor of coronary artery disease as hypertriglyceridemia, which is also 
proved in our present study. 
 Comparison between the risk factors of coronary artery disease and 
hyperricemia in males and females showed some statistical correlation for 
biochemical profile mainly. 
TABLE -9 
COMPARISON OF RISK FACTORS IN MALES 
RISK FACTOR CAD (P VALUE) HYPERURICEMIA (P VALUE)
Age >0.05 <0.001 
BMI >0.05 <0.001 
BS – F >0.05 <0.01 
BS – PP >0.05 <0.02 
TC <0.0001 <0.02 
TGL <0.0001 <0.01 
LDL <0.10 (NS) <0.01 
HDL >0.05 >0.05 
    
 This table shows no statistical significance for age, body mass index 
and glycemic control for coronary artery disease but it was significantly 
correlated with hyperuricemia. Lipid profile was significantly correlated for 
both coronary artery disease and hyperuricemia, except for a weak 
correlation for low density lipoprotein cholesterol, and high density 
lipoprotein cholesterol in this subgroup. 
 
TABLE -10 
COMPARISON OF RISK FACTORS IN FEMALES 
RISK FACTOR CAD (P VALUE) HYPERURICEMIA (P VALUE)
Age >0.05 <0.05 
BMI >0.05 <0.05 
BS – F >0.05 <0.01 
BS – PP >0.05 <0.05 
TC >0.05 >0.05 
TGL >0.05 <0.05 
LDL >0.05 <0.05 
HDL >0.05 <0.05 
 
 In females also coronary artery disease was not significantly 
associated with age, body mass index and glycemic control. There was 
correlation between total cholesterol. 
  
 Triglycerides and low density cholesterol and high density lipoprotein 
cholesterol for both the groups except for total cholesterol in hyperuricemia 
group, which was not statistically significant for hyperuricemia. High 
density lipoproteins were relatively higher in both coronary artery disease 
group as well as hyperuricemia group. 
 
 Overall comparative analysis between the risk factors for coronary 
artery disease and hyperuricemia showed no statistical correlation for age, 
sex and body mass index. Glycemic control, even though statistically 
significant it was poor in both subgroups. Total cholesterol showed no 
statistical significance but hypertriglyceridemia was present in both groups. 
(>150mg%) 
 
 
 
 
TABLE -11 
COMPARISON BETWEEN THE RISK FACTORS 
PARAMETERS 
PATIENTS WITH AND 
WITHOUT CORONARY 
ARTERY DISEASE 
PATIENTS WITH 
AND WITHOUT 
HYPERURICEMIA  
Age >0.05 >0.05 
Sex >0.05 >0.05 
BMI >0.05 >0.05 
BS – Fasting <0.05 <0.001 
BS – Postprandial >0.05 <0.001 
TC >0.05 >0.05 
TGL <0.01 <0.001 
LDL >0.05 >0.05 
HDL <0.02 >0.05 
  
  Low density lipoprotein cholesterol was also not significant in our 
study in both groups. Low levels of high density cholesterol was not 
associated in our study. 
 
  
 
  
            To summarize, the results in our study, there is significant 
association between the risk factors for coronary artery disease as well as 
hyperuricemia. There was significant elevation of uric acid in association 
with presence of coronary artery disease. Considering all these factors it can 
be concluded that presence of hyperuricemia in type-2 diabetes indicates 
increased incidence of coronary artery disease and seems to be a marker for 
coronary artery disease.  
 
    
 
 
 
 
 
 
 
 
 
 DISCUSSION 
  
   Except for very few studies much has not been studied about the 
serum uric acid level as an important measure of this important dysmetabolic 
syndrome called as type-2 diabetes mellitus. “In the absence of gout 
presence of hyperuricemia in patients with type-2 diabetes mellitus is an 
important marker as well as added risk factor for atherosclerosis”. 
 
 Even though there are many controversial argument about elevated 
serum uric acid as a risk factor there some of the studies, which proved it. As 
well as there are few studies, which considered it as marker in combination 
with other risk factors particularly elevated levels of triglycerides, which is 
also an important risk factor in acceleration of atherosclerosis according to 
various studies recently. Our study also proved a significant association of 
elevated serum uric acid with hypertriglyceridemia. 
 
 A study by Pearl A et al (J Ed Cyst 1993 Aug: 17(3-4): 233-7) found 
out uric acid as a free radical scavenger by estimating the relationship 
between the serum irate and the Molar Equivalent Serum Anti-oxidant 
(MESA) in diabetic and normal individuals and found a linear relationship 
between serum uric acid and MESA. Significant differences between the two 
groups were both mean MESA values and mean uric acid values.  
  
 According to another recent study conducted in Lomo Medical Clinic, 
The Heart of Africa, Cardiovascular center, Kinshasa, Congo by Longo-
Mbenza B et al with the background of “uric acid stabilizes the platelet 
aggregation and enhances thrombotic tendency” suggested hyperuricemia as 
a strong predictor of myocardial infarction and stroke and all causes of 
mortality. (Int J Cardiol 1999 Sept; 30; (1): 17-22). 
 
 Tkac l et al in a similar study like our present study with 91 type-2 
diabetics, in which 57 patients had clinical and ECG evidence of old 
myocardial infarction was compared with a control group of 34 diabetics 
without any evidence of coronary heart disease. There were significantly 
higher mean serum uric acid values in the whole group with the Ml. Biserial 
regression analysis showed the persistent significance between the serum 
uric acid level, even after elimination of age and serum creatinine levels. 
 
 The author favored the view that uric acid is rather a marker than true 
risk factor of atherosclerosis in type-2 diabetes mellitus (Vnitr Lek 1990 
Aug; 36(8): 763-8). 
PRESENT STUDY LIPIDS INDIANS MALES FEMALES  AMERICANS 
TC 192.2+31.8 201.7+48.3 203.8+58.6 177+25.3 
TGL 174.1+18.1 155.7+47.9 190.7+78.2 85.9+45.8 
LDL-C 126.8+28.5 131.5+45.2 129.9+48.2 119.5+22.3 
HDL-C 36.2+7 39.2+4.9 39.4+3.7 40.3+8.2 
TC/HDL 5.53+1.42 5.15+0.91 5.18+0.89 4.55+0.88 
LDL/HDL 3.56+0.96 3.35+0.81 3.28+0.85 3.09+0.88 
    
 As there are many references with regard to newly emerging risk 
factors to coronary heart disease like Hypertriglyceridemia, Lipoprotein (a), 
small dense LDL, our present study has thrown light on 
hypertriglyceridemia as an important risk factor for coronary heart disease, 
which was also independently associated with elevation of serum uric acid 
level. 
 Diabetic dyslipidemia is major problem adding to the atherogenicity 
in type-2 diabetes mellitus in our patients both in the control group as well 
as infarction group. A comparison between the serum lipids Indians with our 
study population and American population is as follows.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 CONCLUSION 
 
 Mean serum uric acid level in diabetic population in our study was 
comparable to normal range in the general population. 
 
 There was no significant difference in serum uric acid between the 
diabetics without any evidence of coronary heart disease and the general 
population. 
 
 When there is elevated serum uric acid in diabetics that can be 
considered as a marker of coronary heart disease in diabetics. 
 
 Elevated uric acid may be an epiphenomenona due to associated other 
coronary heart disease risk factors. 
 
 Our study also found out that significant elevation of Triglycerides in 
both the groups with and without coronary heart disease which is more 
significant in patients with coronary heart disease. It also has been observed 
that elevated uric acid is associated with hypertriglyceridemia.  
  
 
                                    SUMMARY 
 
               The  study “serum uric acid- A marker of coronary artery disease in 
type 2- diabetes mellitus” is a cross sectional study conducted on a random 
selection of patients suffering from type 2 DM from wards, OP’s, review 
OP’s and diabetology clinic  with in GOVT. Rajaji Hospital, Madurai.  93 
patients were studied out of which 7 were excluded as they had ischaemic 
changes in electrocardiogram. 
                The rest were divided in to two groups , one without any evidence 
of CAD, clinically and electrocardiographically. The other had evidence of 
CAD. The following clinical parameters such as duration of diabetes, age of 
onset, prior history of HT, CAD, CVA, smoking, alcoholism was assesed . 
BMI calculated, blood pressure was measured in both lying and in standing 
position to rule out autonomic neuropathy. 
           Patients who were suffering from chronic disease such as tuberculosis 
or chronic leg ulcer were excluded . Urine PCR was done to rule out early 
renal involvement . Basic biochemical parameters like blood urea, serum 
creatinine were done. Fasting and postprandial blood glucose was done to 
assses the glycaemic status and a complete lipid profile was done. 
         
 
          Along with this serum uric acid level was estimated in the fasting state 
and a single channel ECG was taken in all patients .Those who had old 
myocardial infarction pattern or normal ECG pattern were included and the 
rest were excluded.  
          Mean serum uric acid level in diabetic population in our study was 
comparable to normal range in the general population. There was no 
significant difference in serum uric acid between the diabetics without any 
evidence of coronary heart disease and the general population. 
           When there is elevated serum uric acid in diabetics that can be 
considered as a marker of coronary heart disease in Diabetics. It was also  
observed that elevated uric acid is associated with hypertriglyceridemia.  
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 THE  PROFORMA   FOR  THE STUDY 
 
 
“ URIC ACID –A MARKER OFCORONARY ARTERY DISEASE    IN  TYPE 2 
DIABETES MELLITUS” 
 
NAME                                                 : 
 
 
AGE                                                                   :  
 
 
SEX                                                                    : 
 
RESEDENTIAL ADDRESS                             : 
 
 
SOCIOECONOMIC STATUS                          : 
 
 
OCCUPATION                                                  : 
 
 
TYPE 2 DIABETES MELLITUS                    DURATION:                    AGE OF 
ONSET: 
 
 
HYPERTENSION                                            : 
 
 
h/o  CAD/STROKE                              : 
 
 
Smoking                               : 
 
Alcohol                    : 
 
 
Type of personality                                             :  
 
 
Present medication                               : 
 
 
 
Height:                                       Weight:                                               BMI: 
 
 
Pulse rate:                  Blood pressure:                 W/H ratio: 
 
 
Urine protienuria/24 Hrs urinary protein/spot PCR: 
 
 
 
Blood glucose                              fasting:                               post prandial: 
 
Blood urea: 
 
Serum creatinine   
 
                     
LIPID PROFILE    
 
  Total cholesterol:                            TGL:      
                            
   VLDL:                              LDL:  
 
    HDL: 
 
 
 
ELECTROCARDIOGRAM: 
 
 
 
 
 
SERUM URIC ACID: 
 
                                          GLOSSARY 
 
ATP- Adenosine triphosphate 
BMI- Body mass index 
BUN- Blood urea nitrogen 
CAD- Coronary artery disease 
DM- Diabetes mellitus 
ECF-Extra cellular fluid 
ECG- Electrocardiogram 
GFR- Glomerular filtration rate 
HDL- High density lipoprotein 
HT- Hyperytension 
IDL- Intermediate density lipoprotein 
LDL-low density lipoprotein 
MRFIT-Multiple risk factor intervention trial 
NIDDM- Non insulin dependantdiabetes mellitus 
OP- Out patient 
PGI2- prostacyclin 
SUA-Serum uric acid 
TGL- Triglycerides 
TXA2-Thromoxane A 2 
VLDL- Very low density lipoprotein 
WHR- Weight hip ratio 
             
 
 
 
